A mutation in the KRAS gene is associated with improved overall survival in pancreatic ductal adenocarcinoma compared with other variants, according to a multicenter study conducted at Weill Cornell Medicine, NewYork-Presbyterian and other institutions.
A new study emphasizes the importance of considering sex differences in Alzheimer’s research – a step that could ultimately lead to more precise and effective treatments.
A powerful new analytical tool offers a closer look at how tumor cells “shape-shift” to become more aggressive and untreatable, as shown in a study from researchers at Weill Cornell Medicine and the New York Genome Center.
A new preclinical model using CRISPR has given Weill Cornell Medicine researchers and their colleagues a deeper insight into how prostate cancer spreads or metastasizes.
A multi-institutional clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators showed that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with traditional biopsy approaches.
Immunocompromised people with persistent COVID infections can harbor drug-resistant variants of the virus, which have the potential to spread, researchers at Weill Cornell Medicine, the College of Veterinary Medicine and the NIH have found.
A new study from Weill Cornell Medicine researchers helps explain why having ApoE4 – the gene variant most closely linked to Alzheimer’s disease – increases the risk of neurodegeneration and white matter damage.
A smart sensor that attaches to the tip of a syringe can measure, in real time, the concentration and viability of the cells that pass through it – a potential breakthrough for biomedical 3D printing and cell therapy.
About half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or more, according to a report from Weill Cornell Medicine and Dana-Farber Cancer Center investigators.
